Cargando…
Antiplatelet Therapy in Diabetes: Efficacy and Limitations of Current Treatment Strategies and Future Directions
Autor principal: | Angiolillo, Dominick J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2660456/ https://www.ncbi.nlm.nih.gov/pubmed/19336638 http://dx.doi.org/10.2337/dc08-2064 |
Ejemplares similares
-
Immunotherapy for the Prevention and Treatment of Type 1 Diabetes: Human trials and a look into the future
por: Rewers, Marian, et al.
Publicado: (2009) -
Immunotherapy for the Prevention and Treatment of Type 1 Diabetes: Optimizing the path from bench to bedside
por: Bresson, Damien, et al.
Publicado: (2009) -
Diabetes: Have We Got It All Wrong?: Insulin hypersecretion and food additives: cause of obesity and diabetes?
por: Corkey, Barbara E.
Publicado: (2012) -
Insulin, Insulin Resistance, and Platelet Signaling in Diabetes
por: Randriamboavonjy, Voahanginirina, et al.
Publicado: (2009) -
Factors Contributing to Increased Platelet Reactivity in People With Diabetes
por: Schneider, David J.
Publicado: (2009)